MolNFT v2 · #87564 · protein
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1
4C4E: “Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1”. X-ray diffraction at 2.6. MolNFT v2 #87564 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4C4E
- Type
- protein
- Length
- 257 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.6
- Source
- HOMO SAPIENS
- UniProt
- P33981
Structure
x-ray diffraction · resolution 2.6 · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 257 | — | P33981 |
Compared structures
- 4C4E · Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic… · the same entry in another collection · chain A against A, TM-score 1.00
- P33981 · AlphaFold monomer V2.0 prediction for dual specificity protein kinase ttk (P33981) · a predicted model of the same protein · chain A against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P33981
- Elsewhere: RCSB PDB 4C4E · PDBe 4C4E · UniProt P33981
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.